Abstract 1752: SY-13380, a novel menin-MLL inhibitor, exhibits efficacy against resistant mutations and anti-tumor activity for MLL-rearranged and NPM1-mutant acute myeloid leukemia in pre-clinical models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Xiaopeng Li, Tiantian Hao, Hongjuan Li, Chang Lu, Shikang Cheng, Xinhe Xu, Huiyan Luo, Xijie Liu, Hong Luo, Yinghui Sun
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409628060